MiuraTSogaYMiyashitaY. Five-year prognosis after
endovascular therapy in claudicant patients with iliofemoral artery
disease. J Endovasc Ther.2014;21:381–388.
2.
NorgrenLHiattWRDormandyJA. Inter-society consensus for the
management of peripheral arterial disease. Int
Angiol.2007;26:81–157.
3.
WhymanMRFowkesFGKerracherEM. Is intermittent claudication improved
by percutaneous transluminal angioplasty? A randomized controlled
trial. J Vasc Surg.1997;26:551–557.
4.
WhymanMRFowkesFGKerracherEM. Randomised controlled trial of
percutaneous transluminal angioplasty for intermittent
claudication. Eur J Vasc Endovasc Surg.1996;12:167–172.
5.
CreasyTSMcMillanPJFletcherEW. Is percutaneous transluminal
angioplasty better than exercise for claudication? Preliminary results from
a prospective randomised trial. Eur J Vasc
Surg.1990;4:135–140.
6.
PerkinsJMColinJCreasyTS. Exercise training versus angioplasty
for stable claudication. Long and medium term results of a prospective
randomised trial. Eur J Vasc Endovasc Surg.1996;11:409–413.
7.
WilsonSE.
Trials of endovascular treatment for superficial femoral
artery occlusive lesions: a call for medically managed control
patients. Ann Vasc Surg.2010;24:498–502.
8.
FransFABipatSReekersJA. Systematic review of exercise
training or percutaneous transluminal angioplasty for intermittent
claudication. Br J Surg.2012;99:16–28.
9.
MazariFAKhanJACarradiceD. Randomized clinical trial of
percutaneous transluminal angioplasty, supervised exercise and combined
treatment for intermittent claudication due to femoropopliteal arterial
disease. Br J Surg.2012;99:39–48
10.
LiuJWuYLiZ. Endovascular treatment for
intermittent claudication in patients with peripheral arterial disease: a
systematic review. Ann Vasc Surg.2013 Dec 14 [Epub ahead of print].
11.
LeonASConnettJJacobsDR. Leisure-time physical activity levels
and risk of coronary heart disease and death. The Multiple Risk Factor
Intervention Trial. JAMA.1987;258:2388–2395.
12.
PateRRPrattMBlairSN. Physical activity and public health.
A recommendation from the Centers for Disease Control and Prevention and the
American College of Sports Medicine. JAMA.1995;273:402–407.
13.
PaffenbargerRSHydeRTWingAL. The association of changes in
physical-activity level and other lifestyle characteristics with mortality
among men. N Engl J Med.1993;328:538–545.
14.
BreekJCHammingJFDe VriesJ. Quality of life in patients with
intermittent claudication using the World Health Organisation (WHO)
questionnaire. Eur J Vasc Endovasc Surg.2001;21:118–122.
15.
BarlettaGPernaSSabbaC. Quality of life in patients with
intermittent claudication: relationship with laboratory exercise
performance. Vasc Med.1996;1:3–7.
16.
HirschATHaskalZJHertzerNR. ACC/AHA 2005 guidelines for the
management of patients with peripheral arterial disease (lower extremity,
renal, mesenteric, and abdominal aortic): executive summary a collaborative
report from the American Association for Vascular Surgery/Society for
Vascular Surgery, Society for Cardiovascular Angiography and Interventions,
Society for Vascular Medicine and Biology, Society of Interventional
Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing
Committee to Develop Guidelines for the Management of Patients With
Peripheral Arterial Disease) endorsed by the American Association of
Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood
Institute; Society for Vascular Nursing; TransAtlantic Inter-Society
Consensus; and Vascular Disease Foundation.
Circulation.2006;113:e463–654.
17.
KeelingANNaughtonPAO'ConnellA. Does percutaneous transluminal
angioplasty improve quality of life?J Vasc Interv Radiol.2008;19:169–176.
18.
NewmanABShemanskiLManolioTA. Ankle-arm index as a predictor of
cardiovascular disease and mortality in the Cardiovascular Health Study. The
Cardiovascular Health Study Group. Arterioscler
Thromb Vasc Biol.1999;19:538–545.
19.
McKennaMWolfsonSKullerL. The
ratio of ankle and arm arterial pressure as an independent predictor of
mortality. Atherosclerosis.1991;87:119–128.
20.
BreekJCHammingJFDe VriesJ. Quality of life in patients with
intermittent claudication using the World Health Organisation (WHO)
questionnaire. Eur J Vasc Endovasc Surg.2001;21:118–122.
21.
BrevettiGSchianoVChiarielloM.
Endothelial dysfunction: a key to the pathophysiology and
natural history of peripheral arterial disease?Atherosclerosis.2008;197:1–11.
22.
HusmannMDorffler-MellyJKalkaC. Successful lower extremity
angioplasty improves brachial artery flow-mediated dilation in patients with
peripheral arterial disease. J Vasc Surg.2008;48:1211–1216.
23.
KhairaHSNashGBBahraPS. Thromboxane and neutrophil changes
following intermittent claudication suggest ischaemia-reperfusion
injury. Eur J Vasc Endovasc Surg.1995;10:31–35.
24.
AllaqabandSKirvaitisRJanF. Endovascular treatment of peripheral
vascular disease. Curr Probl Cardiol.2009;34:359–476.
25.
PencinaMJD'AgostinoRBLarsonMG. Predicting the 30-year risk of
cardiovascular disease: the Framingham Heart Study.
Circulation.2009;119:3078–3084.
